Literature DB >> 22318854

Optineurin immunoreactivity in neuronal nuclear inclusions of polyglutamine diseases (Huntington's, DRPLA, SCA2, SCA3) and intranuclear inclusion body disease.

Fumiaki Mori, Kunikazu Tanji, Yasuko Toyoshima, Mari Yoshida, Akiyoshi Kakita, Hitoshi Takahashi, Koichi Wakabayashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22318854     DOI： 10.1007/s00401-012-0956-x

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  9 in total

1.  From the Cover: Alterations in Optineurin Expression and Localization in Pre-clinical Parkinson's Disease Models.

Authors:  John Pierce Wise; Jason Cannon
Journal:  Toxicol Sci       Date:  2016-07-29       Impact factor: 4.849

2.  Optineurin immunoreactivity in neuronal and glial intranuclear inclusions in adult-onset neuronal intranuclear inclusion disease.

Authors:  Masataka Nakamura; Melissa E Murray; Wen-Lang Lin; Hirofumi Kusaka; Dennis W Dickson
Journal:  Am J Neurodegener Dis       Date:  2014-09-06

Review 3.  Autophagy and neurodegeneration.

Authors:  Rebecca A Frake; Thomas Ricketts; Fiona M Menzies; David C Rubinsztein
Journal:  J Clin Invest       Date:  2015-01-02       Impact factor: 14.808

4.  Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism.

Authors:  Wen-Chuan Shen; Huei-Ying Li; Guang-Chao Chen; Yijuang Chern; Pang-Hsien Tu
Journal:  Autophagy       Date:  2015-04-03       Impact factor: 16.016

5.  Visual impairment in an optineurin mouse model of primary open-angle glaucoma.

Authors:  Henry C Tseng; Thorfinn T Riday; Celia McKee; Catherine E Braine; Howard Bomze; Ian Barak; Carrie Marean-Reardon; Simon W M John; Benjamin D Philpot; Michael D Ehlers
Journal:  Neurobiol Aging       Date:  2015-02-27       Impact factor: 4.673

Review 6.  Emerging views of OPTN (optineurin) function in the autophagic process associated with disease.

Authors:  Yueping Qiu; Jincheng Wang; Hui Li; Bo Yang; Jiajia Wang; Qiaojun He; Qinjie Weng
Journal:  Autophagy       Date:  2021-04-13       Impact factor: 16.016

7.  Loss of optineurin in vivo results in elevated cell death and alters axonal trafficking dynamics.

Authors:  Jeremiah D Paulus; Brian A Link
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

8.  FUS/TLS acts as an aggregation-dependent modifier of polyglutamine disease model mice.

Authors:  Yoshihiro Kino; Chika Washizu; Masaru Kurosawa; Mizuki Yamada; Hiroshi Doi; Toru Takumi; Hiroaki Adachi; Masahisa Katsuno; Gen Sobue; Geoffrey G Hicks; Nobutaka Hattori; Tomomi Shimogori; Nobuyuki Nukina
Journal:  Sci Rep       Date:  2016-10-14       Impact factor: 4.379

9.  Examination of Huntington's disease in a Chinese family.

Authors:  Mingxia Yu; Xiaogai Li; Sanyun Wu; Ji Shen; Jiancheng Tu
Journal:  Neural Regen Res       Date:  2014-02-15       Impact factor: 5.135
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.